Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336505
Status:
COMPLETED
Last Update Posted:
2010-02-26
First Post:
2006-06-09
Brief Title:
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia CAP
Sponsor:
Advanced Life Sciences Inc
Organization:
Advanced Life Sciences Inc
Organization Data
Organization:
Advanced Life Sciences Inc
Class:
INDUSTRY
Study ID:
CL05-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Advanced Life Sciences Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
David Eiznhamer PhD Executive Vice President Clinical Development
Old Organization:
Advanced Life Sciences